The customer reported false elevated alinity c total bilirubin results for neonates compared to the gasometer (b)(4), radiometer-spectrophotometry).The customer provided the following for four patients: sid: (b)(6): initial = 15.53 mg/dl, repeat 15.96 mg/dl, and gasometer = 11.5 mg/dl; sid: (b)(6): initial = 15.28 mg/dl, repeats = 14.92 mg/dl, 13.25 mg/dl(dil 1:5), 12.43 mg/dl (dil 1:10), & gasometer 11.6 mg/dl; sid: (b)(6): initial = 14.42 mg/dl, and gasometer = 11.2 mg/dl; sid: (b)(6): initial = 15.42 mg/dl, and gasometer = 11.9 mg/dl.There was no reported impact to patient management there was no reported impact to patient management.
|
The evaluation of the customer¿s issue included a search for similar complaints, ticket trending review, labeling review, device history record review.A review of tickets determined that there is normal complaint activity for lot 57809uq07.Trending review determined no trend for falsely elevated results for the product.Return testing was not completed as returns were not available.The customer reports that all alinity total bilirubin quality control results are within expected ranges; this appears to be a patient sample specific event.A review of the manufacturing documentation did not identify any issues associated with the customer's observation.A review of the product labeling concluded that the issue is sufficiently addressed.Based on all available information no systemic issue or product deficiency was identified.
|